| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.44 | 0.04 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |